Candel Therapeutics (CADL) EPS (Basic) (2020 - 2025)
Candel Therapeutics (CADL) posted EPS (Basic) of -$0.29 for Q4 2025, up 33.26% sequentially from -$0.43 in Q3 2025, and down 7.41% YoY from -$0.31 in Q4 2024.
Candel Therapeutics (CADL) EPS (Basic) (2020 - 2025) Analysis & Trends
Candel Therapeutics has reported EPS (Basic) for 6 years, with the latest figure at -$0.29 in Q4 2025.
- Quarterly EPS (Basic) fell 7.41% year-over-year to -$0.29 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$1.54 (up 31.62% YoY) and the FY2025 annual result came in at -$2.07, down 9.49% from the prior year.
- EPS (Basic) grew to -$0.29 in Q4 2025 per CADL's latest filing, from -$0.43 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.27 in Q4 2024 and troughed at -$1.38 in Q4 2021.
- A 5-year average of -$0.52 and a median of -$0.38 in 2021 frame the typical range for EPS (Basic).
- The widest YoY moves for EPS (Basic): up 77.49% in 2022, down 231.74% in 2022.
- Over 5 years, EPS (Basic) stood at -$1.38 in 2021, then soared by 77.49% to -$0.31 in 2022, then slipped by 12.52% to -$0.35 in 2023, then grew by 23.53% to -$0.27 in 2024, then retreated by 7.41% to -$0.29 in 2025.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.29, -$0.43, and -$0.42 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Candel Therapeutics | 643.41 Mn | 643.41 Mn | - | -0.29 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.29 |
| Sep 30, 2025 | -0.43 |
| Jun 30, 2025 | -0.42 |
| Mar 31, 2025 | -0.42 |
| Dec 31, 2024 | -0.27 |
| Sep 30, 2024 | -0.90 |
| Jun 30, 2024 | -0.86 |
| Mar 31, 2024 | -0.28 |
| Dec 31, 2023 | -0.35 |
| Sep 30, 2023 | -0.33 |
| Jun 30, 2023 | -0.68 |
| Mar 31, 2023 | -0.35 |
| Dec 31, 2022 | -0.31 |
| Sep 30, 2022 | -0.31 |
| Jun 30, 2022 | -0.32 |
| Mar 31, 2022 | -1.33 |
| Dec 31, 2021 | -1.38 |
| Sep 30, 2021 | -0.34 |
| Jun 30, 2021 | -0.45 |
| Mar 31, 2021 | -0.40 |